Correlation Between Biochemical and Immunological Alterations with Updated Therapies in Alzheimer’s Disease: A Review Article
Bahir Abdul Razzaq Mshimesh1, Basma Talib Al-Sudani2, Suzan Yousif Jasim2
1Department of Pharmacology & Toxicology, College of Pharmacy, Mustansiriyah University, Baghdad-Iraq
2Department of Clinical Laboratory Sciences, College of Pharmacy, Mustansiriyah University, Baghdad-Iraq
Received: 29-Dec-2018 , Accepted: 28-Jan-2019
Keywords: Alzheimer`s disease, Neuropathology, New biomarkers, Update targeting therapies
Full Text HTML
How to Cite this Article
Bahir Abdul Razzaq Mshimesh, Basma Talib Al-Sudani, Suzan Yousif Jasim. Correlation Between Biochemical and Immunological Alterations with Updated Therapies in Alzheimer’s Disease: A Review Article. PBJ. 2019; 7(1): 31-41.
Alzheimer`s disease (AD) is the most widely recognized reason for dementia in more advanced age subjects and it`s a vital general medical issue. Since Alzheimer portrayed the primary instance of the AD over a century back, much advancement has been made in reading the pathogenic and clinical findings of this disorder. Generous progression was made in describing pre-dementia phases of the AD, for example, mild cognitive impairment (MCI), and enhancing the diagnostic and treatment choices accessible for overseeing AD. Our capacity to discover the `fix` for AD eventually depends not just on possessing an exact view of the cellular procedures, but additionally on having ideal biomarkers and valuable neuroimaging tests to empower early analysis and convenient helpful mediation in suspected people. The object for this article is to give a short review to the AD and the related researches in this field. The article accentuates clinical and neurobiological parts of the AD. Furthermore, this survey portrays progress in the utilization of biomarkers for analysis of AD and features continuous endeavors to create novel treatments.